Tg(Slc18a2)1Gwmil
Transgene Detail
|
|
| Symbol: |
Tg(Slc18a2)1Gwmil |
| Name: |
transgene insertion 1, Gary Miller |
| MGI ID: |
MGI:7439351 |
| Synonyms: |
VMAT2-HI |
| Transgene: |
Tg(Slc18a2)1Gwmil Location: unknown
|
| Alliance: |
Tg(Slc18a2)1Gwmil page
|
|
| Strain of Origin: |
Not Specified
|
|
| Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The transgene contains BAC RP23-292H20. Line 1 contains three copies of the transgene with high expression levels relative to the other lines generated.
(J:212154)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:212154 Lohr KM, et al., Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proc Natl Acad Sci U S A. 2014 Jul 8;111(27):9977-82 |
| All: |
1 reference(s) |
|
Analysis Tools
